The current financial score of Hims & Hers Health Inc is 7.60. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 753.21M, representing a year-over-year increase of 38.25%, while its net profit experienced a year-over-year increase of 303.01%.
The current valuation score of Hims & Hers Health Inc is 8.71. Its current P/E ratio is -502.60, which is -154.72% below the recent high of 275.02 and -320.13% above the recent low of -2111.58.
The current earnings forecast score of Hims & Hers Health Inc is 6.50. The average price target is 31.53, with a high of 42.00 and a low of 23.46.
The current price momentum score of Hims & Hers Health Inc is 5.31. Currently, the stock price is trading between the resistance level at 32.72 and the support level at 24.99, making it suitable for range-bound swing trading.
The current institutional shareholding score of Hims & Hers Health Inc is 10.00. The latest institutional shareholding proportion is 93.60%, representing a quarter-over-quarter decrease of 2.32%.
The current risk assessment score of Hims & Hers Health Inc is 4.02. The company's beta value is 2.38. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.